Cadrenal Therapeutics, Inc. (CVKD) shareholders
Close on Nov 17, 2026Market cap $6.71MP/E –Yield 877.66%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Quang X. Pham Joint filing with The PVBQ Living Trust (11.20%) | 421,042 | 23.60% | 13D (active) | Jan 23, 2025 |
| The PNC Financial Services Group, Inc. | 233,219 | 8.13% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CVKD | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 50,137 | 1.41% | $167.46K | +4,936 | 0.00% |
| Hrt Financial LP | 29,055 | 0.81% | $97.00K | New | 0.00% |
| Geode Capital Management, LLC | 19,024 | 0.53% | $63.54K | −2,602 | 0.00% |
| Vanguard Fiduciary Trust Co | 8,311 | 0.23% | $27.76K | – | 0.00% |
| Tower Research Capital LLC (TRC) | 1,282 | 0.04% | $4.28K | +889 | 0.00% |
| UBS Group AG | 1,112 | 0.03% | $3.71K | +1,109 | 0.00% |
| Grove Bank & Trust | 1,000 | 0.03% | $3.34K | New | 0.00% |
| Morgan Stanley | 706 | 0.02% | $2.36K | +606 | 0.00% |
| Clearstead Advisors, LLC | 650 | 0.02% | $2.17K | New | 0.00% |
| Quest 10 Wealth Builders, Inc. | 380 | 0.01% | $1.27K | New | 0.00% |
| Osaic Holdings, Inc. | 300 | 0.01% | $1.00K | – | 0.00% |
| Rockefeller Capital Management L.P. | 150 | 0.00% | $501 | – | 0.00% |
| Wells Fargo & Company/Mn | 99 | 0.00% | $331 | – | 0.00% |
| Barclays PLC | 93 | 0.00% | $311 | New | 0.00% |
| Integrated Wealth Concepts LLC | 86 | 0.00% | $287 | New | 0.00% |
| Archer Investment Corp | 70 | 0.00% | $234 | +35 | 0.00% |
| IFP Advisors, Inc | 30 | 0.00% | $100 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 17 | 0M | 3.2% | 6 / 5 | 1 / 5 | 0M | 0M |
| Q1 2026 | 17 | 0M | 2.5% | 5 / 2 | 5 / 5 | 0M | 0M |
| Q4 2025 | 18 | 0M | 3.4% | 3 / 4 | 3 / 2 | 0M | 0M |
| Q3 2025 | 17 | 0M | 3.4% | 5 / 3 | 3 / 2 | 0M | 0M |
| Q2 2025 | 14 | 0M | 1.9% | 4 / 3 | 3 / 3 | 0M | 0M |
| Q1 2025 | 13 | 0M | 1.9% | 7 / 4 | 1 / 3 | 0M | 0M |
| Q4 2024 | 9 | 0M | 0.4% | 8 / 1 | 0 / 1 | 0M | 0M |
| Q3 2024 | 2 | 0M | 0.0% | 2 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
8 funds held CVKD in Q2 2026, 73% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of CVKD | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 33,278 | 0.93% | $111.15K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 16,859 | 0.47% | $56.31K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 12,307 | 0.34% | $60.43K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 2,449 | 0.07% | $12.02K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 2,041 | 0.06% | $10.02K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 1,109 | 0.03% | $5.45K | 0.00% | May 31, 2026 |
| Dimensional US Sustainability Core 1 ETF | 914 | 0.03% | $1.84K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Quang X. Pham | Chairman and CEO, Director, 10% owner | 298,589 | 8.37% | Oct 13, 2026 |
| Jeffrey Scott Cole | Chief Operating Officer | – | – | Oct 13, 2026 |
| Matthew K. Szot | Chief Financial Officer | 0 | – | Dec 31, 2025 |
| James J. Ferguson III | Chief Medical Officer | – | – | Feb 6, 2025 |
| Glynn Wilson | Director | 50,000 | 1.40% | Oct 13, 2026 |
| Lee Scott Golden | Director | 1,667 | 0.05% | Oct 13, 2026 |
| John Raymond Murphy | Director | 614,792 | 17.23% | Oct 13, 2026 |
| Steven Zelenkofske | Director | 40,000 | 1.12% | Jan 24, 2025 |
| Robert Lisicki | Director | – | – | Jan 24, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Quang X. Pham Chairman and CEO, Director, 10% owner | Jun 29, 2026 | Sale(10b5-1 plan) | −7,400 | $3.03 | $22.42K | 98,589 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 26, 2026 | Sale(10b5-1 plan) | −9,029 | $3.05 | $27.54K | 105,989 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 25, 2026 | Sale(10b5-1 plan) | −2,127 | $3.00 | $6.38K | 115,018 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 23, 2026 | Sale(10b5-1 plan) | −2,277 | $3.20 | $7.29K | 117,145 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 22, 2026 | Sale(10b5-1 plan) | −9,167 | $3.55 | $32.54K | 119,422 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 17, 2026 | Sale(10b5-1 plan) | −513 | $3.16 | $1.62K | 128,589 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 16, 2026 | Sale(10b5-1 plan) | −3,613 | $3.18 | $11.49K | 129,102 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 15, 2026 | Sale(10b5-1 plan) | −3,666 | $3.58 | $13.12K | 132,715 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 12, 2026 | Sale(10b5-1 plan) | −12,996 | $3.94 | $51.20K | 136,381 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 11, 2026 | Sale(10b5-1 plan) | −1,462 | $4.12 | $6.02K | 149,377 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 10, 2026 | Sale(10b5-1 plan) | −3,500 | $4.21 | $14.74K | 150,839 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 9, 2026 | Sale(10b5-1 plan) | −12,992 | $4.06 | $52.75K | 154,339 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 8, 2026 | Sale(10b5-1 plan) | −5,893 | $4.38 | $25.81K | 167,331 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Jun 5, 2026 | Sale(10b5-1 plan) | −2,064 | $4.42 | $9.12K | 173,224 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Jun 4, 2026 | Sale(10b5-1 plan) | −3,898 | $4.41 | $17.19K | 175,288 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Jun 3, 2026 | Sale(10b5-1 plan) | −2,323 | $4.26 | $9.90K | 179,186 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Jun 2, 2026 | Sale(10b5-1 plan) | −349 | $4.46 | $1.56K | 181,509 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | May 29, 2026 | Sale(10b5-1 plan) | −303 | $5.01 | $1.52K | 181,858 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | May 28, 2026 | Sale(10b5-1 plan) | −2,989 | $4.93 | $14.74K | 182,161 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | May 22, 2026 | Sale(10b5-1 plan) | −1,165 | $5.69 | $6.63K | 194,924 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | May 12, 2026 | Sale(10b5-1 plan) | −3,298 | $5.28 | $17.41K | 185,150 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | May 11, 2026 | Sale(10b5-1 plan) | −6,476 | $5.76 | $37.30K | 188,448 |
| Matthew K. Szot Chief Financial Officer | Dec 29, 2025 | Sale(10b5-1 plan) | −9,933 | $6.97 | $69.23K | 0 |
| Matthew K. Szot Chief Financial Officer | Oct 27, 2025 | Sale(10b5-1 plan) | −1,800 | $13.99 | $25.18K | 9,933 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Oct 27, 2025 | Sale(10b5-1 plan) | −1,315 | $13.99 | $18.40K | 196,089 |
| Matthew K. Szot Chief Financial Officer | Oct 24, 2025 | Sale(10b5-1 plan) | −1,800 | $13.99 | $25.18K | 11,733 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Oct 24, 2025 | Sale(10b5-1 plan) | −1,129 | $14.03 | $15.84K | 197,404 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Oct 13, 2025 | Sale(10b5-1 plan) | −1,800 | $14.15 | $25.47K | 198,533 |
| Matthew K. Szot Chief Financial Officer | Oct 13, 2025 | Sale(10b5-1 plan) | −1,800 | $14.07 | $25.33K | 13,533 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Oct 9, 2025 | Sale(10b5-1 plan) | −1,800 | $14.02 | $25.24K | 200,333 |
| Matthew K. Szot Chief Financial Officer | Oct 9, 2025 | Sale(10b5-1 plan) | −1,693 | $13.99 | $23.69K | 15,333 |
| Matthew K. Szot Chief Financial Officer | Oct 6, 2025 | Sale(10b5-1 plan) | −107 | $13.99 | $1.50K | 17,026 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Oct 2, 2025 | Sale(10b5-1 plan) | −500 | $14.13 | $7.07K | 202,133 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Oct 1, 2025 | Sale(10b5-1 plan) | −881 | $14.01 | $12.34K | 202,633 |
| Matthew K. Szot Chief Financial Officer | Oct 1, 2025 | Sale(10b5-1 plan) | −1,700 | $13.99 | $23.78K | 17,133 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Sep 29, 2025 | Sale(10b5-1 plan) | −419 | $14.01 | $5.87K | 203,514 |
| Matthew K. Szot Chief Financial Officer | Sep 29, 2025 | Sale(10b5-1 plan) | −100 | $14.00 | $1.40K | 18,833 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Sep 25, 2025 | Sale(10b5-1 plan) | −6,790 | $14.09 | $95.67K | 203,933 |
| Matthew K. Szot Chief Financial Officer | Sep 25, 2025 | Sale(10b5-1 plan) | −10,900 | $14.05 | $153.15K | 18,933 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Sep 24, 2025 | Sale(10b5-1 plan) | −2,581 | $13.99 | $36.11K | 210,723 |
| Matthew K. Szot Chief Financial Officer | Sep 24, 2025 | Sale(10b5-1 plan) | −1,500 | $14.00 | $21.00K | 29,833 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Aug 28, 2025 | Sale(10b5-1 plan) | −1,193 | $13.99 | $16.69K | 213,304 |
| Matthew K. Szot Chief Financial Officer | Aug 28, 2025 | Sale(10b5-1 plan) | −400 | $14.00 | $5.60K | 31,333 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Aug 27, 2025 | Sale(10b5-1 plan) | −3,836 | $13.99 | $53.67K | 214,497 |
| Matthew K. Szot Chief Financial Officer | Aug 27, 2025 | Sale(10b5-1 plan) | −1,600 | $14.00 | $22.40K | 31,733 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Apr 10, 2024 | Gift | −50,000 | – | – | 3,275,000 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Oct 23, 2023 | Gift | −85,000 | – | – | 3,325,000 |
| John Raymond Murphy Director | Oct 5, 2023 | Buy | +2,669 | $0.69 | $1.84K | 614,792 |
| John Raymond Murphy Director | Oct 4, 2023 | Buy | +17,331 | $0.70 | $12.13K | 612,123 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Sep 5, 2023 | Buy | +20,000 | $0.90 | $18.00K | 3,410,000 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Sep 5, 2023 | Buy | +20,000 | $0.91 | $18.20K | 3,390,000 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Sep 1, 2023 | Buy | +20,000 | $0.92 | $18.40K | 3,350,000 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Sep 1, 2023 | Buy | +20,000 | $0.93 | $18.60K | 3,330,000 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Sep 1, 2023 | Buy | +10,000 | $0.92 | $9.20K | 3,360,000 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Sep 1, 2023 | Buy | +10,000 | $0.84 | $8.40K | 3,370,000 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Sep 1, 2023 | Buy | +10,000 | $0.93 | $9.30K | 3,310,000 |
| John Raymond Murphy Director | Mar 21, 2023 | Buy | +10,000 | $1.39 | $13.90K | 594,792 |
| John Raymond Murphy Director | Mar 16, 2023 | Buy | +20,000 | $1.67 | $33.40K | 574,792 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Feb 10, 2023 | Award | +25,000 | $1.94 | $48.50K | 3,300,000 |
| Glynn Wilson Director | Jan 24, 2023 | Conversion | +50,000 | – | – | 50,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Cadrenal Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 431,035 shares on Sep 1, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Quang X. Pham Officer | Jun 15, 2026 | 40,000 | $148.40K | Jun 15, 2026 | Founders Shares |
| Quang X. Pham Officer | May 11, 2026 | 60,000 | $348.60K | May 11, 2026 | Founders Shares |
| Matthew K. Szot Officer | Dec 29, 2025 | 9,933 | $73.60K | Dec 29, 2025 | Founders Shares |
| Quang X. Pham Officer | Oct 27, 2025 | 1,315 | $18.40K | Oct 27, 2025 | Founders Shares |
| Matthew K. Szot Officer | Oct 27, 2025 | 1,800 | $25.44K | Oct 27, 2025 | Founders Shares |
| Quang X. Pham Officer | Oct 24, 2025 | 1,129 | $15.84K | Oct 24, 2025 | Founders Shares |
| Matthew K. Szot Officer | Oct 24, 2025 | 1,800 | $24.79K | Oct 24, 2025 | Founders Shares |
| Quang X. Pham Officer | Oct 14, 2025 | 1,800 | $25.47K | Oct 13, 2025 | Founders Shares |
| Matthew K. Szot Officer | Oct 14, 2025 | 1,800 | $24.52K | Oct 13, 2025 | Founders Shares |
| Matthew K. Szot Officer | Oct 9, 2025 | 1,693 | $23.63K | Oct 9, 2025 | Founders Shares |
| Quang X. Pham Officer | Oct 9, 2025 | 1,800 | $25.23K | Oct 9, 2025 | Founders Shares |
| Matthew K. Szot Officer | Oct 6, 2025 | 107 | $1.52K | Oct 6, 2025 | Founders Shares |
| Quang X. Pham Officer | Oct 2, 2025 | 500 | $7.07K | Oct 2, 2025 | Founders Shares |
| Quang X. Pham Officer | Oct 1, 2025 | 881 | $12.34K | Oct 1, 2025 | Founders Shares |
| Matthew K. Szot Officer | Oct 1, 2025 | 1,700 | $23.51K | Oct 1, 2025 | Founders Shares |
See a number that looks wrong?